drugset
drugset / Trial / NCT05017844

[KSR-001-P02] Phase 2b/3 Study, Evaluate the Efficacy and Safety of KSR-001 in Patients With Dry Eye Syndrome

NCT05017844 ↗

Phase 2/3 Completed 222 enrolled Kukje Pharma Samil Pharmaceutical Co., Ltd. · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of KSR-001 in patients with Dry Eye Syndrome

Timeline

Start
2020-02-18
Primary completion
2021-02-08
Completion
2021-06-22

Drugs

EvaluationDrugModalityDoseRoute
Subject KSR-001-02 Unknown — Topical
Subject KSR-001-03 Unknown — Topical

Indications

dry eye syndrome